EVP, Drug Development
Wed, Jan 13, 2021
Jan 13
433 shares @ $18.16
Decreased holdings by -34.60%
10th largest trade (out of 63)
Cluster Buy
Trade made by an officer
Part of a cluster of 3 transactions by 3 insiders
Price 10% above 200-day moving average